Myocept, Inc.

We develop topical recombinant proteins for anti-wrinkle markets not served by Botox because of aversion to needles and toxicity concerns.

  • Stage Product In Development
  • Industry Biotechnology
  • Location San Francisco, CA, USA
  • Currency USD
  • Founded December 2008
  • Employees 3
  • Website myocept.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free